-
公开(公告)号:US20180362652A1
公开(公告)日:2018-12-20
申请号:US15869514
申请日:2018-01-12
Applicant: Biogen MA Inc.
Abstract: Antibodies and antibody fragments that bind to BDCA2 are disclosed. Also disclosed are methods of using the antibodies and antibody fragments to induce death of a plasmacytoid dendritic cell, inhibit production or secretion of inflammatory cytokines and chemokines, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions.
-
公开(公告)号:US09902775B2
公开(公告)日:2018-02-27
申请号:US14649297
申请日:2013-12-10
Applicant: Biogen MA Inc.
CPC classification number: C07K16/2851 , A61K2039/505 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/54 , C07K2317/55 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/626 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/76 , C07K2317/92
Abstract: Antibodies and antibody fragments that bind to BDCA2 are disclosed. Also disclosed are methods of using the antibodies and antibody fragments to induce death of a plasmacytoid dendritic cell, inhibit production or secretion of inflammatory cytokines and chemokines, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions.
-